- Molecules
- 25
MedsAcross lists 25 molecules linked to Chronic lymphocytic leukemia, each with brands, manufacturers and supply from India for licensed hospitals and physicians.
Medicines used
Molecules linked to this condition in public data. The prescriber decides which treatment is right.
- PrednisoneCorticosteroid11 presentationsA07EA03
- DexamethasoneOrphanCorticosteroid30 presentations8 brandsA01AC02
- LenalidomideOrphanThalidomide Analog12 presentations6 brandsL04AX04
- Cyclophosphamide18 presentations1 brandL01AA01
- DoxorubicinOrphanAnthracycline Topoisomerase Inhibitor15 presentations5 brandsL01DB01
- NilotinibOrphanKinase Inhibitor10 presentations5 brandsL01EA03
- CladribinePurine Antimetabolite4 presentations3 brandsL01BB04
- BendamustineOrphanAlkylating Drug9 presentations5 brandsL01AA09
- PegfilgrastimOrphanLeukocyte Growth Factor10 presentations20 brandsL03AA13
- IfosfamideOrphanAlkylating Drug5 presentations1 brandL01AA06
- RituximabOrphanCD20-directed Cytolytic Antibody8 presentations11 brandsL01FA01
- MercaptopurineOrphanNucleoside Metabolic Inhibitor2 presentations1 brandL01BB02
- IbrutinibOrphanKinase Inhibitor6 presentations2 brandsL01EL01
- VenetoclaxOrphanBCL-2 Inhibitor4 presentations2 brandsL01XX52
- DuvelisibOrphan2 presentations1 brandL01EM04
- VincristineOrphanVinca Alkaloid2 presentationsL01CA02
- AlemtuzumabOrphanCD52-directed Cytolytic Antibody2 presentations3 brandsL01XC04
- AcalabrutinibOrphanKinase Inhibitor2 presentations2 brandsL01EL02
- IdelalisibOrphanKinase Inhibitor2 presentations2 brandsL01XX47
- PirtobrutinibOrphanKinase Inhibitor2 presentations2 brandsL01
- ChlorambucilAlkylating Drug1 presentation1 brandL01AA02
- ObinutuzumabOrphanCD20-directed Cytolytic Antibody1 presentation2 brandsL01FA03
- OfatumumabOrphanCD20-directed Cytolytic Antibody1 presentation2 brandsL01FA02
- PegaspargaseOrphanAsparagine-specific Enzyme1 presentation2 brandsL01XX24
- PentostatinOrphanNucleoside Metabolic Inhibitor1 presentation1 brandL01XX08
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Need a medicine for Chronic lymphocytic leukemia?
Physicians and hospitals can request named-patient supply. We guide you through the documents your country requires.